Ligand profile
ZINC4105016
Virtual-screening candidate from ZINC.
Bound to: KP13_03128 — Beta-lactamase CTX-M-2
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC4105016- UniProt (similar protein)
Q9L5C8- Tanimoto
- 1.000
- Target protein
- KP13_03128
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 66.4
- −1 ≤ LogP ≤ 5 1.62
- MW ≤ 500 Da 241.2
- LogP ≤ 5 1.62
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 66.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(O)[C@@H]1C[C@H]1C(=O)Nc1cc(F)ccc1FO=C(O)[C@@H]1C[C@H]1C(=O)Nc1cc(F)ccc1F
InChI=1S/C11H9F2NO3/c12-5-1-2-8(13)9(3-5)14-10(15)6-4-7(6)11(16)17/h1-3,6-7H,4H2,(H,14,15)(H,16,17)/t6-,7-/m1/s1InChI=1S/C11H9F2NO3/c12-5-1-2-8(13)9(3-5)14-10(15)6-4-7(6)11(16)17/h1-3,6-7H,4H2,(H,14,15)(H,16,17)/t6-,7-/m1/s1
QTWGHTBKFVANGX-RNFRBKRXSA-NQTWGHTBKFVANGX-RNFRBKRXSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- G30
- Homolog
- Q9L5C8
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC4105016 →
- ZINC ZINC20 ZINC4105016 →
- UniProt UniProt Q9L5C8 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC4105016”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03128.
PDB 52
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 6
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).